Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice R T Bergin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
JCO Global Oncology|March 1, 2022
Insights Into the Demands on a Clinical Oncologist in Sri LankaAlice R T Bergin
F1000Research|August 27, 2019
Triple-negative breast cancer: recent treatment advancesAlice R T Bergin, Sherene Loi
Cancer Immunology Research|June 2, 2023
Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic StatusAlice R T Bergin, Roberto Salgado, Sherene Loi
Histopathology|November 22, 2023
Spatial transcriptomics and the anatomical pathologist: Molecular meets morphologyJia-Min B Pang, David J Byrne, Alice R T Bergin, et al.
Internal Medicine Journal|February 20, 2019
Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre studyEdmond M Kwan, Marie C Semira, Alice R T Bergin, et al.
Asia-Pacific Journal of Clinical Oncology|July 20, 2019
Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer: An Australian case seriesAlice R T Bergin, Stephen J Luen, Peter Savas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 29, 2025
Aboriginal and Torres Strait Islander females and survival from breast cancerAlice R T Bergin, Luc Te Marvelde, Roger L Milne, et al.
Cancer Discovery|December 7, 2018
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast CancerSheau W Lok, James R Whittle, François Vaillant, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
JCO Global Oncology|March 1, 2022
Insights Into the Demands on a Clinical Oncologist in Sri LankaAlice R T Bergin
F1000Research|August 27, 2019
Triple-negative breast cancer: recent treatment advancesAlice R T Bergin, Sherene Loi
Cancer Immunology Research|June 2, 2023
Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic StatusAlice R T Bergin, Roberto Salgado, Sherene Loi
Histopathology|November 22, 2023
Spatial transcriptomics and the anatomical pathologist: Molecular meets morphologyJia-Min B Pang, David J Byrne, Alice R T Bergin, et al.
Internal Medicine Journal|February 20, 2019
Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre studyEdmond M Kwan, Marie C Semira, Alice R T Bergin, et al.
Asia-Pacific Journal of Clinical Oncology|July 20, 2019
Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer: An Australian case seriesAlice R T Bergin, Stephen J Luen, Peter Savas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 29, 2025
Aboriginal and Torres Strait Islander females and survival from breast cancerAlice R T Bergin, Luc Te Marvelde, Roger L Milne, et al.
Cancer Discovery|December 7, 2018
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast CancerSheau W Lok, James R Whittle, François Vaillant, et al.
Pageof 1